Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Oct 16, 2017, 12:30 ET Neue Daten zu PLENVU® (NER1006) beim ACG zeigen überlegene Darmreinigung im Vergleich zu konventionellen Präparaten

Norgine B.V. stellte heute neue Daten vor, die die überlegene Wirksamkeit beim Erzielen einer hochwertigen Darmreinigung (in mindestens einem...


Oct 16, 2017, 11:23 ET Norgine presenta datos del nuevo PLENVU® en el Congreso Mundial de Gastroenterología ACG 2017

- Norgine presenta datos del nuevo PLENVU® (NER1006) en el Congreso Mundial de Gastroenterología ACG 2017 - Dos carteles ganan el Premio de...


Oct 16, 2017, 11:17 ET Datos de PLENVU® muestran limpieza del intestino superior a las preparaciones comúnmente utilizadas

- Datos del nuevo PLENVU® (NER1006) en ACG muestran limpieza del intestino superior a las preparaciones comúnmente utilizadas Norgine B.V....


Oct 16, 2017, 09:00 ET Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Esophageal Cancer

Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor...


Oct 16, 2017, 08:35 ET Clinical Studies of Natural Antiviral Gene-Eden-VIR/Novirin Are Listed on PubMed, the Most Selective and Prestigious Database of Medical Studies

Many people currently use herbal treatments to improve their health. However, some are still reluctant to use those treatments. To discover why, a...


Oct 16, 2017, 08:35 ET Soft Suit Exoskeleton Technology Begins Next Phase of Testing in Pre-Clinical Study

ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") today announced that the soft exosuit technology currently in development has entered the next phase...


Oct 16, 2017, 08:30 ET ReWalk Completes Critical Design Review Processes of Restore System for Move to Clinical Studies

ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") announced today completion of all internal processes to initiate clinical studies and the initial...


Oct 16, 2017, 08:01 ET Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017

Allergan plc (NYSE: AGN) today announced that new data from its gastroenterology portfolio will be featured at the World Congress of...


Oct 16, 2017, 08:01 ET Ardelyx Announces Tenapanor Reduces Pain Caused by IBS-C Through Inhibition of TRPV-1 Signaling

Ardelyx, Inc. (NASDAQ: ARDX) today reported that data from preclinical studies have shown that tenapanor works to reduce abdominal pain caused by...


Oct 16, 2017, 08:00 ET New Post-Hoc Analyses Report Early Symptomatic Improvement in Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Patients Taking Entyvio® (vedolizumab), Particularly in Biologic-Naïve Patients

Takeda Pharmaceutical Company Limited (TSE: 4502), ("Takeda") today announced the presentation of data suggesting early symptomatic improvement in...


Oct 16, 2017, 08:00 ET Regen BioPharma, Inc. Researchers Capitalize on Key Structure in Compounds that Activate Checkpoint NR2F6 for the Potential Treatment of Autoimmune Diseases

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) believes it has taken full advantage of its recent prior discovery in developing small...


Oct 16, 2017, 08:00 ET New Clinical Data and Microbiome Research from Rebiotix's Phase 2 Program for RBX2660 Highlighted at the World Congress of Gastroenterology at ACG2017

Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human microbiome to treat challenging diseases, today...


Oct 16, 2017, 08:00 ET Enzyvant Initiates Farber Disease Natural History Study

Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced the initiation...


Oct 16, 2017, 08:00 ET Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced initiation of a clinical trial evaluating its investigational new drug PEGPH20 with...


Oct 16, 2017, 08:00 ET Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive results from a Phase 2 investigational study of dupilumab in...


Oct 16, 2017, 07:45 ET Agile Therapeutics Presents Additional Twirla® Phase 3 SECURE Study Results at NAFFP 2017

Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's healthcare company, today announced the presentation of additional results from the Phase 3...


Oct 16, 2017, 06:45 ET Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis

New subgroup analysis from Eli Lilly and Company's (NYSE: LLY) Phase 3 REVEL trial of CYRAMZA® (ramucirumab) in advanced non-small cell lung cancer...


Oct 16, 2017, 05:45 ET ChemPass and LifeArc Report Positive Results in the Validation of ChemPass Technology in Medicinal Chemistry Programs

ChemPass, an artificial intelligence technology company and LifeArc, a medical research charity, announced today that they have successfully...


Oct 16, 2017, 05:00 ET Dante Labs macht nicht-invasiven pränatalen Test (NIPT) ohne Fehlgeburtsrisiko allen schwangeren Frauen in Europa verfügbar

Dante Labs fügt seiner Sammlung moderner Gentests den nicht-invasiven pränatalen Test (NIPT) hinzu. Heute stellte die internationale...


Oct 16, 2017, 05:00 ET Prueba prenatal no invasiva (NIPT) de Dante Labs para las mamás europeas embarazadas

- Dante Labs hace una prueba prenatal no invasiva (NIPT) disponible para todas las mamás europeas embarazadas, con riesgo cero de aborto...


Oct 16, 2017, 01:45 ET ChemPass und LifeArc melden positive Ergebnisse bei der Validierung der ChemPass-Technologie in medizinalchemischen Programmen

ChemPass, ein Unternehmen für künstliche Intelligenztechnologie und LifeArc, ein gemeinnütziges medizinisches Forschungsunternehmen haben...


Oct 16, 2017, 00:40 ET BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that the first patients have been enrolled in the Phase 3 clinical trial of...


Oct 15, 2017, 14:00 ET Ionis Presents New Data from NEURO-TTR Study and Highlights Programs from Its Neurological Disease Franchise at ANA Congress

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced that new data from the Phase 3 NEURO-TTR study...


Oct 13, 2017, 16:20 ET Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for STELARA®...


Oct 13, 2017, 16:08 ET CSA Medical to Feature the Rapid AV Catheter at American College of Gastroenterology (ACG); Announces Presentations of truFreeze® Clinical Studies at the Conference

CSA Medical will feature the new Rapid AV catheter in the exhibit hall and hands-on workshops at ACG 2017 in Orlando, FL. This new catheter, which...